David Gorgan

@degorgan

Working on giving more people with genetic diseases a diagnosis, backed by . Former . Founded . 🎥 enthusiast.

Berlin
Vrijeme pridruživanja: veljača 2010.

Tweetovi

Blokirali ste korisnika/cu @degorgan

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @degorgan

  1. proslijedio/la je Tweet

    As we move from reactive to proactive healthcare - diagnostics companies seem undervalued Traditionally, diagnostics have been tools of the provider, but in a proactive model they become the first touch into the health system. Can move into the service layer too.

    Poništi
  2. proslijedio/la je Tweet
    9. sij

    Plz don't take my tech "hot takes" as pessimistic... Plummeting genome sequencing costs + rapid advancements in precision gene editing + AI are biotech's mobile+cloud+AI. The next couple decades will be every bit as head-spinning as the last two.

    Poništi
  3. proslijedio/la je Tweet

    2019 was a watershed year for in clinical care, bringing hope to many patients and families. Here are my thoughts on some of the highlights of this year:

    Poništi
  4. 10. pro 2019.

    Great production quality by the way ! Great to see more high-quality podcasts getting started in Europe

    Prikaži ovu nit
    Poništi
  5. 5. pro 2019.

    We need a better map to be able to decipher which mutations cause genetic diseases. Listen to my co-founder explain how we built this map at and why it matters.

    Prikaži ovu nit
    Poništi
  6. proslijedio/la je Tweet

    More about European tech companies going public, by 👇 Key message: All the big European IPOs happen in the US.

    Poništi
  7. 15. stu 2019.

    Agree with your take on it ! And sometimes it also makes sense to move from boot-strapped to VC-backed (hardly the other way round though)

    Poništi
  8. proslijedio/la je Tweet
    7. stu 2019.

    Super proud to have known this crew for the last 17(!) years. Barry, Austin & Tom What’s funny about this interview is that they’ve saying this the whole time and it sounded crazy back then. Now, looking a lot more real.

    Poništi
  9. proslijedio/la je Tweet
    7. stu 2019.

    A great article David! And congrats to moving to the - excited to keep reading your work! Here are my thoughts on the topic: - hope you enjoy!

    Poništi
  10. proslijedio/la je Tweet
    25. lis 2019.

    I saw a girl building a startup today. No pitching at events. No chasing public funding. No raising capital from toxic angels. She just sat there. Building product & talking to users. Like a Psychopath.

    Poništi
  11. proslijedio/la je Tweet
    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    21. lis 2019.

    Prime editing, a new tool created by /, directly edits human cells in a precise, efficient, and highly versatile fashion. The tool has the potential to correct up to 89% of defects.

    Poništi
  13. proslijedio/la je Tweet
    21. lis 2019.

    Today we describe prime editing, a very versatile new approach to genome editing in human cells without cutting the DNA double helix. We integrated a reverse transcriptase with a disabled CRISPR enzyme to copy virtually any edit from an engineered guide RNA into a target site...

    Prikaži ovu nit
    Poništi
  14. proslijedio/la je Tweet
    12. lis 2019.

    Few people appreciate the “last mile” of UX. Making something _really_ slick is a billion dollar moat. Zoom wasn’t the first. Nor WhatsApp. They’re just... excellent. Take any productivity app, Zoomify it, build yourself an empire. “100ms is the best patent”

    Poništi
  15. proslijedio/la je Tweet
    14. lis 2019.

    I have probably had 500+ VCs on discuss the right way to assess company valuation. “The value of a company is the sum of all the problems they’ve solved” - This is one of my favorites ever from

    Poništi
  16. proslijedio/la je Tweet
    28. ruj 2019.

    Love this! Virtualization of biology will be massively impactful for biotech ecosystem by enabling a democratization of the means to pilot innovation.

    Poništi
  17. proslijedio/la je Tweet
    6. ruj 2019.

    This is top shelf trolling, because thanks to Excel “1 in 5” genetics papers contain errors in gene names.

    Prikaži ovu nit
    Poništi
  18. proslijedio/la je Tweet

    I love talking strategy with early-stage entrepreneurs. The questions they face are both unique and universal: How can I build company culture? How to hire a diverse workforce? I talk with 8 founders from in this strategy session:

    Poništi
  19. 26. ruj 2019.

    "The best people in each ecosystem knew our friends from San Francisco but almost no one from Paris or Berlin." Also realized this recently when trying to help someone in Warsaw with connections. Great tips inside on how to build stronger ties between startup hubs in Europe

    Poništi
  20. proslijedio/la je Tweet
    25. ruj 2019.

    Another great newsletter by on reasons to be optimistic about European tech - including the interesting argument, “Europe has become a developing region again as opposed to a developed one”

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·